Mutation of the tumour suppressor gene TP53 has been related to early tumour progression in multiple cancer types as well as in endometrial cancer, and is associated with grade 3 and with non-endometrial (mostly serous) histology, while POLE mutation leads to only rare recurrence and excellent outcomes20. Here, TP53 is linked to neoplasm.